Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
ENTITY
GC Biopharma Corp (006280 KS)
Watchlist
101
Analysis
Health Care
•
South Korea
GC Biopharma is a biopharmaceutical company headquartered in Yongin, South Korea. It manufactures household medical drugs. The Company's product includes medicines for cold and fever, nutrition, antiseptic drug, and a lip balm.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Quantitative Analysis
•
12 Jun 2024 02:10
KRX Short Interest Weekly (Jun 7th): Samsung Electronics
We analyzed KRX short interest report for the past week. We estimate the short interests were USD 6.1bn last week and highlighted short interest...
Ke Yan, CFA, FRM
Follow
375 Views
Share
bullish
•
Quantitative Analysis
•
29 May 2024 03:29
KRX Short Interest Weekly (May 24th): Samsung Electronics
We analyzed KRX short interest report for the past week and highlighted short interest changes in Samsung Electronics, Samsung SDI, Samsung Electro...
Ke Yan, CFA, FRM
Follow
363 Views
Share
bearish
•
HDC Hyundai Development Co-Engineering & Construction
•
01 Apr 2024 12:39
Korean Holdcos Vs Opcos Gap Trading Opportunities in 2Q 2024
In this insight, we highlight the recent pricing gap divergences of the major Korean holdcos and opcos which could provide trading opportunities in...
Douglas Kim
Follow
542 Views
Share
bearish
•
Quantitative Analysis
•
20 Feb 2024 22:00
KRX Short Interest Weekly (Feb 16th): Enchem, HMM
We have analyzed KRX short interest report for the past week and highlighted short interest weekly changes in Enchem, HMM.
Ke Yan, CFA, FRM
Follow
302 Views
Share
bearish
•
Amorepacific Corp
•
03 Jan 2024 16:42
Korean Holdcos Vs Opcos Gap Trading Opportunities in 1Q 2024
In this insight, we highlight the recent pricing gap divergences of the major Korean holdcos and opcos which could provide trading opportunities in...
Douglas Kim
Follow
853 Views
Share
First
Previous
1
2
3
4
5
6
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.3
x